Global and United States BCG Tuberculosis (TB) Vaccine Market Report & Forecast 2023-2028

Report ID: 1845642 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 BCG Tuberculosis (TB) Vaccine Product Introduction
    1.2 Global BCG Tuberculosis (TB) Vaccine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global BCG Tuberculosis (TB) Vaccine Sales in US$ Million for the Year 2017-2028
        1.2.2 Global BCG Tuberculosis (TB) Vaccine Sales in Volume for the Year 2017-2028
    1.3 United States BCG Tuberculosis (TB) Vaccine Outlook 2017 VS 2022 VS 2028
        1.3.1 United States BCG Tuberculosis (TB) Vaccine Sales in US$ Million for the Year 2017-2028
        1.3.2 United States BCG Tuberculosis (TB) Vaccine Sales in Volume for the Year 2017-2028
    1.4 BCG Tuberculosis (TB) Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States BCG Tuberculosis (TB) Vaccine in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of BCG Tuberculosis (TB) Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 BCG Tuberculosis (TB) Vaccine Market Dynamics
        1.5.1 BCG Tuberculosis (TB) Vaccine Industry Trends
        1.5.2 BCG Tuberculosis (TB) Vaccine Market Drivers
        1.5.3 BCG Tuberculosis (TB) Vaccine Market Challenges
        1.5.4 BCG Tuberculosis (TB) Vaccine Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 BCG Tuberculosis (TB) Vaccine Market Segment by Type
        2.1.1 Immune BCG
        2.1.2 Therapy BCG
    2.2 Global BCG Tuberculosis (TB) Vaccine Market Size by Type
        2.2.1 Global BCG Tuberculosis (TB) Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global BCG Tuberculosis (TB) Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global BCG Tuberculosis (TB) Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States BCG Tuberculosis (TB) Vaccine Market Size by Type
        2.3.1 United States BCG Tuberculosis (TB) Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States BCG Tuberculosis (TB) Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States BCG Tuberculosis (TB) Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 BCG Tuberculosis (TB) Vaccine Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
    3.2 Global BCG Tuberculosis (TB) Vaccine Market Size by Application
        3.2.1 Global BCG Tuberculosis (TB) Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global BCG Tuberculosis (TB) Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global BCG Tuberculosis (TB) Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States BCG Tuberculosis (TB) Vaccine Market Size by Application
        3.3.1 United States BCG Tuberculosis (TB) Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States BCG Tuberculosis (TB) Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States BCG Tuberculosis (TB) Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global BCG Tuberculosis (TB) Vaccine Competitor Landscape by Company
    4.1 Global BCG Tuberculosis (TB) Vaccine Market Size by Company
        4.1.1 Top Global BCG Tuberculosis (TB) Vaccine Manufacturers Ranked by Revenue (2021)
        4.1.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturer (2017-2022)
        4.1.3 Global BCG Tuberculosis (TB) Vaccine Sales by Manufacturer (2017-2022)
        4.1.4 Global BCG Tuberculosis (TB) Vaccine Price by Manufacturer (2017-2022)
    4.2 Global BCG Tuberculosis (TB) Vaccine Concentration Ratio (CR)
        4.2.1 BCG Tuberculosis (TB) Vaccine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of BCG Tuberculosis (TB) Vaccine in 2021
        4.2.3 Global BCG Tuberculosis (TB) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global BCG Tuberculosis (TB) Vaccine Manufacturing Base Distribution, Product Type
        4.3.1 Global BCG Tuberculosis (TB) Vaccine Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers BCG Tuberculosis (TB) Vaccine Product Type
        4.3.3 Date of International Manufacturers Enter into BCG Tuberculosis (TB) Vaccine Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States BCG Tuberculosis (TB) Vaccine Market Size by Company
        4.5.1 Top BCG Tuberculosis (TB) Vaccine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States BCG Tuberculosis (TB) Vaccine Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States BCG Tuberculosis (TB) Vaccine Sales by Players (2020, 2021 & 2022)
5 Global BCG Tuberculosis (TB) Vaccine Market Size by Region
    5.1 Global BCG Tuberculosis (TB) Vaccine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global BCG Tuberculosis (TB) Vaccine Market Size in Volume by Region (2017-2028)
        5.2.1 Global BCG Tuberculosis (TB) Vaccine Sales in Volume by Region: 2017-2022
        5.2.2 Global BCG Tuberculosis (TB) Vaccine Sales in Volume Forecast by Region (2023-2028)
    5.3 Global BCG Tuberculosis (TB) Vaccine Market Size in Value by Region (2017-2028)
        5.3.1 Global BCG Tuberculosis (TB) Vaccine Sales in Value by Region: 2017-2022
        5.3.2 Global BCG Tuberculosis (TB) Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America BCG Tuberculosis (TB) Vaccine Market Size YoY Growth 2017-2028
        6.1.2 North America BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Indonesia
        6.2.9 Thailand
        6.2.10 Malaysia
        6.2.11 Philippines
        6.2.12 Vietnam
    6.3 Europe
        6.3.1 Europe BCG Tuberculosis (TB) Vaccine Market Size YoY Growth 2017-2028
        6.3.2 Europe BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 UK
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America BCG Tuberculosis (TB) Vaccine Market Size YoY Growth 2017-2028
        6.4.2 Latin America BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Brazil
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 GCC Countries
        6.5.5 Egypt
        6.5.6 South Africa
7 Company Profiles
    7.1 Merck
        7.1.1 Merck Corporation Information
        7.1.2 Merck Description and Business Overview
        7.1.3 Merck BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Merck BCG Tuberculosis (TB) Vaccine Products Offered
        7.1.5 Merck Recent Development
    7.2 Sanofi Pasteur
        7.2.1 Sanofi Pasteur Corporation Information
        7.2.2 Sanofi Pasteur Description and Business Overview
        7.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Products Offered
        7.2.5 Sanofi Pasteur Recent Development
    7.3 Japan BCG Lab
        7.3.1 Japan BCG Lab Corporation Information
        7.3.2 Japan BCG Lab Description and Business Overview
        7.3.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Products Offered
        7.3.5 Japan BCG Lab Recent Development
    7.4 China National Biotec
        7.4.1 China National Biotec Corporation Information
        7.4.2 China National Biotec Description and Business Overview
        7.4.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 China National Biotec BCG Tuberculosis (TB) Vaccine Products Offered
        7.4.5 China National Biotec Recent Development
    7.5 Serum Institute of India
        7.5.1 Serum Institute of India Corporation Information
        7.5.2 Serum Institute of India Description and Business Overview
        7.5.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Products Offered
        7.5.5 Serum Institute of India Recent Development
    7.6 Intervax
        7.6.1 Intervax Corporation Information
        7.6.2 Intervax Description and Business Overview
        7.6.3 Intervax BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Intervax BCG Tuberculosis (TB) Vaccine Products Offered
        7.6.5 Intervax Recent Development
    7.7 GSBPL
        7.7.1 GSBPL Corporation Information
        7.7.2 GSBPL Description and Business Overview
        7.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Products Offered
        7.7.5 GSBPL Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 BCG Tuberculosis (TB) Vaccine Industry Chain Analysis
    8.2 BCG Tuberculosis (TB) Vaccine Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 BCG Tuberculosis (TB) Vaccine Distributors
    8.3 BCG Tuberculosis (TB) Vaccine Production Mode & Process
    8.4 BCG Tuberculosis (TB) Vaccine Sales and Marketing
        8.4.1 BCG Tuberculosis (TB) Vaccine Sales Channels
        8.4.2 BCG Tuberculosis (TB) Vaccine Distributors
    8.5 BCG Tuberculosis (TB) Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. BCG Tuberculosis (TB) Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. BCG Tuberculosis (TB) Vaccine Market Trends
    Table 3. BCG Tuberculosis (TB) Vaccine Market Drivers
    Table 4. BCG Tuberculosis (TB) Vaccine Market Challenges
    Table 5. BCG Tuberculosis (TB) Vaccine Market Restraints
    Table 6. Global BCG Tuberculosis (TB) Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States BCG Tuberculosis (TB) Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global BCG Tuberculosis (TB) Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States BCG Tuberculosis (TB) Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top BCG Tuberculosis (TB) Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global BCG Tuberculosis (TB) Vaccine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global BCG Tuberculosis (TB) Vaccine Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global BCG Tuberculosis (TB) Vaccine Sales Share by Manufacturer, 2017-2022
    Table 15. Global BCG Tuberculosis (TB) Vaccine Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global BCG Tuberculosis (TB) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global BCG Tuberculosis (TB) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Tuberculosis (TB) Vaccine as of 2021)
    Table 18. Top Players of BCG Tuberculosis (TB) Vaccine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers BCG Tuberculosis (TB) Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into BCG Tuberculosis (TB) Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top BCG Tuberculosis (TB) Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States BCG Tuberculosis (TB) Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States BCG Tuberculosis (TB) Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States BCG Tuberculosis (TB) Vaccine Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States BCG Tuberculosis (TB) Vaccine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global BCG Tuberculosis (TB) Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global BCG Tuberculosis (TB) Vaccine Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global BCG Tuberculosis (TB) Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global BCG Tuberculosis (TB) Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global BCG Tuberculosis (TB) Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific BCG Tuberculosis (TB) Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Merck Corporation Information
    Table 43. Merck Description and Business Overview
    Table 44. Merck BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Merck BCG Tuberculosis (TB) Vaccine Product
    Table 46. Merck Recent Development
    Table 47. Sanofi Pasteur Corporation Information
    Table 48. Sanofi Pasteur Description and Business Overview
    Table 49. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Sanofi Pasteur Product
    Table 51. Sanofi Pasteur Recent Development
    Table 52. Japan BCG Lab Corporation Information
    Table 53. Japan BCG Lab Description and Business Overview
    Table 54. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Japan BCG Lab Product
    Table 56. Japan BCG Lab Recent Development
    Table 57. China National Biotec Corporation Information
    Table 58. China National Biotec Description and Business Overview
    Table 59. China National Biotec BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. China National Biotec Product
    Table 61. China National Biotec Recent Development
    Table 62. Serum Institute of India Corporation Information
    Table 63. Serum Institute of India Description and Business Overview
    Table 64. Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Serum Institute of India Product
    Table 66. Serum Institute of India Recent Development
    Table 67. Intervax Corporation Information
    Table 68. Intervax Description and Business Overview
    Table 69. Intervax BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Intervax Product
    Table 71. Intervax Recent Development
    Table 72. GSBPL Corporation Information
    Table 73. GSBPL Description and Business Overview
    Table 74. GSBPL BCG Tuberculosis (TB) Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. GSBPL Product
    Table 76. GSBPL Recent Development
    Table 77. Key Raw Materials Lists
    Table 78. Raw Materials Key Suppliers Lists
    Table 79. BCG Tuberculosis (TB) Vaccine Customers List
    Table 80. BCG Tuberculosis (TB) Vaccine Distributors List
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. BCG Tuberculosis (TB) Vaccine Product Picture
    Figure 2. Global BCG Tuberculosis (TB) Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global BCG Tuberculosis (TB) Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. Global BCG Tuberculosis (TB) Vaccine Sales 2017-2028 (K Units)
    Figure 5. United States BCG Tuberculosis (TB) Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States BCG Tuberculosis (TB) Vaccine Market Size 2017-2028 (US$ Million)
    Figure 7. United States BCG Tuberculosis (TB) Vaccine Sales 2017-2028 (K Units)
    Figure 8. United States BCG Tuberculosis (TB) Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States BCG Tuberculosis (TB) Vaccine Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. BCG Tuberculosis (TB) Vaccine Report Years Considered
    Figure 11. Product Picture of Immune BCG
    Figure 12. Product Picture of Therapy BCG
    Figure 13. Global BCG Tuberculosis (TB) Vaccine Market Share by Type in 2022 & 2028
    Figure 14. Global BCG Tuberculosis (TB) Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2017-2028) & (K Units)
    Figure 17. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global BCG Tuberculosis (TB) Vaccine Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States BCG Tuberculosis (TB) Vaccine Market Share by Type in 2022 & 2028
    Figure 20. United States BCG Tuberculosis (TB) Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States BCG Tuberculosis (TB) Vaccine Sales by Type (2017-2028) & (K Units)
    Figure 23. United States BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States BCG Tuberculosis (TB) Vaccine Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Hospital
    Figure 26. Product Picture of Clinic
    Figure 27. Global BCG Tuberculosis (TB) Vaccine Market Share by Application in 2022 & 2028
    Figure 28. Global BCG Tuberculosis (TB) Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2017-2028) & (K Units)
    Figure 31. Global BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global BCG Tuberculosis (TB) Vaccine Price by Application (2017-2028) & (USD/Unit)
    Figure 33. United States BCG Tuberculosis (TB) Vaccine Market Share by Application in 2022 & 2028
    Figure 34. United States BCG Tuberculosis (TB) Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States BCG Tuberculosis (TB) Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States BCG Tuberculosis (TB) Vaccine Sales by Application (2017-2028) & (K Units)
    Figure 37. United States BCG Tuberculosis (TB) Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States BCG Tuberculosis (TB) Vaccine Price by Application (2017-2028) & (USD/Unit)
    Figure 39. North America BCG Tuberculosis (TB) Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. United States BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Mexico BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe BCG Tuberculosis (TB) Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. UK BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Vietnam BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America BCG Tuberculosis (TB) Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Brazil BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Middle East & Africa BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Turkey BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. GCC Countries BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Egypt BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. South Africa BCG Tuberculosis (TB) Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. BCG Tuberculosis (TB) Vaccine Value Chain
    Figure 73. BCG Tuberculosis (TB) Vaccine Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Frequently Asked Questions
BCG Tuberculosis (TB) Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
BCG Tuberculosis (TB) Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
BCG Tuberculosis (TB) Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Venous Access Port

Venous Access Port market is segmented by region (country), players, by Type and by Application.  ... Read More

Cine Lenses

Cine Lenses market is segmented by region (country), players, by Type and by Application. Players ... Read More